世界の根分岐部病変市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bifurcation Lesions Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0748
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、根分岐部病変のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワンステント、ツーステント）、用途別市場規模（冠状血管、末梢血管）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・根分岐部病変の市場動向
・企業の競争状況、市場シェア
・根分岐部病変の種類別市場規模（ワンステント、ツーステント）
・根分岐部病変の用途別市場規模（冠状血管、末梢血管）
・根分岐部病変の北米市場規模2016-2027（アメリカ、カナダ）
・根分岐部病変のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・根分岐部病変のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・根分岐部病変の中南米市場規模2016-2027（メキシコ、ブラジル）
・根分岐部病変の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boston Scientific Corporation、Abbott、Cardinal Health、Medtronic、C. R. Bard, Inc.、Johnson & Johnson Services, Inc.、Spectranetics、Terumo Medical Corporation）
・結論

A artery narrowing occuring adjacent to,
and/or involving, the origin of a significant side
branch.
North America dominated the bifurcation lesions market in 2016. The region is expected to maintain its dominance during the forecast period. This can be attributed to local presence of major market players, higher disposable income, and favorable reimbursement policies.

Market Analysis and Insights: Global Bifurcation Lesions Market
The global Bifurcation Lesions market size is projected to reach US$ 2023.7 million by 2026, from US$ 1621.9 million in 2019, at a CAGR of 3.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bifurcation Lesions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bifurcation Lesions market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bifurcation Lesions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bifurcation Lesions market.

Global Bifurcation Lesions Scope and Market Size
Bifurcation Lesions market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bifurcation Lesions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
One-Stent
Two-Stent

Segment by Application
Coronary Vascular
Peripheral Vascular

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boston Scientific Corporation
Abbott
Cardinal Health
Medtronic
C. R. Bard, Inc.
Johnson & Johnson Services, Inc.
Spectranetics
Terumo Medical Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bifurcation Lesions Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 One-Stent
1.2.3 Two-Stent
1.3 Market by Application
1.3.1 Global Bifurcation Lesions Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Coronary Vascular
1.3.3 Peripheral Vascular
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bifurcation Lesions Market Perspective (2016-2027)
2.2 Bifurcation Lesions Growth Trends by Regions
2.2.1 Bifurcation Lesions Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bifurcation Lesions Historic Market Share by Regions (2016-2021)
2.2.3 Bifurcation Lesions Forecasted Market Size by Regions (2022-2027)
2.3 Bifurcation Lesions Industry Dynamic
2.3.1 Bifurcation Lesions Market Trends
2.3.2 Bifurcation Lesions Market Drivers
2.3.3 Bifurcation Lesions Market Challenges
2.3.4 Bifurcation Lesions Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bifurcation Lesions Players by Revenue
3.1.1 Global Top Bifurcation Lesions Players by Revenue (2016-2021)
3.1.2 Global Bifurcation Lesions Revenue Market Share by Players (2016-2021)
3.2 Global Bifurcation Lesions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bifurcation Lesions Revenue
3.4 Global Bifurcation Lesions Market Concentration Ratio
3.4.1 Global Bifurcation Lesions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bifurcation Lesions Revenue in 2020
3.5 Bifurcation Lesions Key Players Head office and Area Served
3.6 Key Players Bifurcation Lesions Product Solution and Service
3.7 Date of Enter into Bifurcation Lesions Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bifurcation Lesions Breakdown Data by Type
4.1 Global Bifurcation Lesions Historic Market Size by Type (2016-2021)
4.2 Global Bifurcation Lesions Forecasted Market Size by Type (2022-2027)

5 Bifurcation Lesions Breakdown Data by Application
5.1 Global Bifurcation Lesions Historic Market Size by Application (2016-2021)
5.2 Global Bifurcation Lesions Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bifurcation Lesions Market Size (2016-2027)
6.2 North America Bifurcation Lesions Market Size by Type
6.2.1 North America Bifurcation Lesions Market Size by Type (2016-2021)
6.2.2 North America Bifurcation Lesions Market Size by Type (2022-2027)
6.2.3 North America Bifurcation Lesions Market Size by Type (2016-2027)
6.3 North America Bifurcation Lesions Market Size by Application
6.3.1 North America Bifurcation Lesions Market Size by Application (2016-2021)
6.3.2 North America Bifurcation Lesions Market Size by Application (2022-2027)
6.3.3 North America Bifurcation Lesions Market Size by Application (2016-2027)
6.4 North America Bifurcation Lesions Market Size by Country
6.4.1 North America Bifurcation Lesions Market Size by Country (2016-2021)
6.4.2 North America Bifurcation Lesions Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bifurcation Lesions Market Size (2016-2027)
7.2 Europe Bifurcation Lesions Market Size by Type
7.2.1 Europe Bifurcation Lesions Market Size by Type (2016-2021)
7.2.2 Europe Bifurcation Lesions Market Size by Type (2022-2027)
7.2.3 Europe Bifurcation Lesions Market Size by Type (2016-2027)
7.3 Europe Bifurcation Lesions Market Size by Application
7.3.1 Europe Bifurcation Lesions Market Size by Application (2016-2021)
7.3.2 Europe Bifurcation Lesions Market Size by Application (2022-2027)
7.3.3 Europe Bifurcation Lesions Market Size by Application (2016-2027)
7.4 Europe Bifurcation Lesions Market Size by Country
7.4.1 Europe Bifurcation Lesions Market Size by Country (2016-2021)
7.4.2 Europe Bifurcation Lesions Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bifurcation Lesions Market Size (2016-2027)
8.2 Asia-Pacific Bifurcation Lesions Market Size by Type
8.2.1 Asia-Pacific Bifurcation Lesions Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bifurcation Lesions Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bifurcation Lesions Market Size by Type (2016-2027)
8.3 Asia-Pacific Bifurcation Lesions Market Size by Application
8.3.1 Asia-Pacific Bifurcation Lesions Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bifurcation Lesions Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bifurcation Lesions Market Size by Application (2016-2027)
8.4 Asia-Pacific Bifurcation Lesions Market Size by Region
8.4.1 Asia-Pacific Bifurcation Lesions Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bifurcation Lesions Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bifurcation Lesions Market Size (2016-2027)
9.2 Latin America Bifurcation Lesions Market Size by Type
9.2.1 Latin America Bifurcation Lesions Market Size by Type (2016-2021)
9.2.2 Latin America Bifurcation Lesions Market Size by Type (2022-2027)
9.2.3 Latin America Bifurcation Lesions Market Size by Type (2016-2027)
9.3 Latin America Bifurcation Lesions Market Size by Application
9.3.1 Latin America Bifurcation Lesions Market Size by Application (2016-2021)
9.3.2 Latin America Bifurcation Lesions Market Size by Application (2022-2027)
9.3.3 Latin America Bifurcation Lesions Market Size by Application (2016-2027)
9.4 Latin America Bifurcation Lesions Market Size by Country
9.4.1 Latin America Bifurcation Lesions Market Size by Country (2016-2021)
9.4.2 Latin America Bifurcation Lesions Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bifurcation Lesions Market Size (2016-2027)
10.2 Middle East & Africa Bifurcation Lesions Market Size by Type
10.2.1 Middle East & Africa Bifurcation Lesions Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bifurcation Lesions Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bifurcation Lesions Market Size by Type (2016-2027)
10.3 Middle East & Africa Bifurcation Lesions Market Size by Application
10.3.1 Middle East & Africa Bifurcation Lesions Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bifurcation Lesions Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bifurcation Lesions Market Size by Application (2016-2027)
10.4 Middle East & Africa Bifurcation Lesions Market Size by Country
10.4.1 Middle East & Africa Bifurcation Lesions Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bifurcation Lesions Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Details
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Bifurcation Lesions Introduction
11.1.4 Boston Scientific Corporation Revenue in Bifurcation Lesions Business (2016-2021)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Bifurcation Lesions Introduction
11.2.4 Abbott Revenue in Bifurcation Lesions Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Details
11.3.2 Cardinal Health Business Overview
11.3.3 Cardinal Health Bifurcation Lesions Introduction
11.3.4 Cardinal Health Revenue in Bifurcation Lesions Business (2016-2021)
11.3.5 Cardinal Health Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Bifurcation Lesions Introduction
11.4.4 Medtronic Revenue in Bifurcation Lesions Business (2016-2021)
11.4.5 Medtronic Recent Development
11.5 C. R. Bard, Inc.
11.5.1 C. R. Bard, Inc. Company Details
11.5.2 C. R. Bard, Inc. Business Overview
11.5.3 C. R. Bard, Inc. Bifurcation Lesions Introduction
11.5.4 C. R. Bard, Inc. Revenue in Bifurcation Lesions Business (2016-2021)
11.5.5 C. R. Bard, Inc. Recent Development
11.6 Johnson & Johnson Services, Inc.
11.6.1 Johnson & Johnson Services, Inc. Company Details
11.6.2 Johnson & Johnson Services, Inc. Business Overview
11.6.3 Johnson & Johnson Services, Inc. Bifurcation Lesions Introduction
11.6.4 Johnson & Johnson Services, Inc. Revenue in Bifurcation Lesions Business (2016-2021)
11.6.5 Johnson & Johnson Services, Inc. Recent Development
11.7 Spectranetics
11.7.1 Spectranetics Company Details
11.7.2 Spectranetics Business Overview
11.7.3 Spectranetics Bifurcation Lesions Introduction
11.7.4 Spectranetics Revenue in Bifurcation Lesions Business (2016-2021)
11.7.5 Spectranetics Recent Development
11.8 Terumo Medical Corporation
11.8.1 Terumo Medical Corporation Company Details
11.8.2 Terumo Medical Corporation Business Overview
11.8.3 Terumo Medical Corporation Bifurcation Lesions Introduction
11.8.4 Terumo Medical Corporation Revenue in Bifurcation Lesions Business (2016-2021)
11.8.5 Terumo Medical Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bifurcation Lesions Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of One-Stent
Table 3. Key Players of Two-Stent
Table 4. Global Bifurcation Lesions Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bifurcation Lesions Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bifurcation Lesions Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bifurcation Lesions Market Share by Regions (2016-2021)
Table 8. Global Bifurcation Lesions Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bifurcation Lesions Market Share by Regions (2022-2027)
Table 10. Bifurcation Lesions Market Trends
Table 11. Bifurcation Lesions Market Drivers
Table 12. Bifurcation Lesions Market Challenges
Table 13. Bifurcation Lesions Market Restraints
Table 14. Global Bifurcation Lesions Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bifurcation Lesions Market Share by Players (2016-2021)
Table 16. Global Top Bifurcation Lesions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifurcation Lesions as of 2020)
Table 17. Ranking of Global Top Bifurcation Lesions Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bifurcation Lesions Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bifurcation Lesions Product Solution and Service
Table 21. Date of Enter into Bifurcation Lesions Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bifurcation Lesions Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bifurcation Lesions Revenue Market Share by Type (2016-2021)
Table 25. Global Bifurcation Lesions Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bifurcation Lesions Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bifurcation Lesions Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bifurcation Lesions Revenue Market Share by Application (2016-2021)
Table 29. Global Bifurcation Lesions Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bifurcation Lesions Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bifurcation Lesions Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bifurcation Lesions Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bifurcation Lesions Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bifurcation Lesions Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bifurcation Lesions Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bifurcation Lesions Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bifurcation Lesions Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bifurcation Lesions Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bifurcation Lesions Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bifurcation Lesions Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bifurcation Lesions Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bifurcation Lesions Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bifurcation Lesions Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bifurcation Lesions Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bifurcation Lesions Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bifurcation Lesions Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bifurcation Lesions Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bifurcation Lesions Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bifurcation Lesions Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bifurcation Lesions Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bifurcation Lesions Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bifurcation Lesions Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bifurcation Lesions Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bifurcation Lesions Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bifurcation Lesions Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bifurcation Lesions Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bifurcation Lesions Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bifurcation Lesions Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bifurcation Lesions Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bifurcation Lesions Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boston Scientific Corporation Company Details
Table 62. Boston Scientific Corporation Business Overview
Table 63. Boston Scientific Corporation Bifurcation Lesions Product
Table 64. Boston Scientific Corporation Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 65. Boston Scientific Corporation Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Bifurcation Lesions Product
Table 69. Abbott Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Cardinal Health Company Details
Table 72. Cardinal Health Business Overview
Table 73. Cardinal Health Bifurcation Lesions Product
Table 74. Cardinal Health Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 75. Cardinal Health Recent Development
Table 76. Medtronic Company Details
Table 77. Medtronic Business Overview
Table 78. Medtronic Bifurcation Lesions Product
Table 79. Medtronic Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 80. Medtronic Recent Development
Table 81. C. R. Bard, Inc. Company Details
Table 82. C. R. Bard, Inc. Business Overview
Table 83. C. R. Bard, Inc. Bifurcation Lesions Product
Table 84. C. R. Bard, Inc. Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 85. C. R. Bard, Inc. Recent Development
Table 86. Johnson & Johnson Services, Inc. Company Details
Table 87. Johnson & Johnson Services, Inc. Business Overview
Table 88. Johnson & Johnson Services, Inc. Bifurcation Lesions Product
Table 89. Johnson & Johnson Services, Inc. Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Services, Inc. Recent Development
Table 91. Spectranetics Company Details
Table 92. Spectranetics Business Overview
Table 93. Spectranetics Bifurcation Lesions Product
Table 94. Spectranetics Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 95. Spectranetics Recent Development
Table 96. Terumo Medical Corporation Company Details
Table 97. Terumo Medical Corporation Business Overview
Table 98. Terumo Medical Corporation Revenue in Bifurcation Lesions Business (2016-2021) & (US$ Million)
Table 99. Terumo Medical Corporation Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bifurcation Lesions Market Share by Type: 2020 VS 2027
Figure 2. One-Stent Features
Figure 3. Two-Stent Features
Figure 4. Global Bifurcation Lesions Market Share by Application: 2020 VS 2027
Figure 5. Coronary Vascular Case Studies
Figure 6. Peripheral Vascular Case Studies
Figure 7. Bifurcation Lesions Report Years Considered
Figure 8. Global Bifurcation Lesions Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Bifurcation Lesions Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Bifurcation Lesions Market Share by Regions: 2020 VS 2027
Figure 11. Global Bifurcation Lesions Market Share by Regions (2022-2027)
Figure 12. Global Bifurcation Lesions Market Share by Players in 2020
Figure 13. Global Top Bifurcation Lesions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifurcation Lesions as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Bifurcation Lesions Revenue in 2020
Figure 15. Global Bifurcation Lesions Revenue Market Share by Type (2016-2021)
Figure 16. Global Bifurcation Lesions Revenue Market Share by Type (2022-2027)
Figure 17. North America Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Bifurcation Lesions Market Share by Type (2016-2027)
Figure 19. North America Bifurcation Lesions Market Share by Application (2016-2027)
Figure 20. North America Bifurcation Lesions Market Share by Country (2016-2027)
Figure 21. United States Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bifurcation Lesions Market Share by Type (2016-2027)
Figure 25. Europe Bifurcation Lesions Market Share by Application (2016-2027)
Figure 26. Europe Bifurcation Lesions Market Share by Country (2016-2027)
Figure 27. Germany Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bifurcation Lesions Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Bifurcation Lesions Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Bifurcation Lesions Market Share by Region (2016-2027)
Figure 37. China Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bifurcation Lesions Market Share by Type (2016-2027)
Figure 45. Latin America Bifurcation Lesions Market Share by Application (2016-2027)
Figure 46. Latin America Bifurcation Lesions Market Share by Country (2016-2027)
Figure 47. Mexico Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bifurcation Lesions Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Bifurcation Lesions Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Bifurcation Lesions Market Share by Country (2016-2027)
Figure 53. Turkey Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Bifurcation Lesions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Boston Scientific Corporation Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 57. Abbott Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 58. Cardinal Health Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 59. Medtronic Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 60. C. R. Bard, Inc. Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 61. Johnson & Johnson Services, Inc. Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 62. Spectranetics Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 63. Terumo Medical Corporation Revenue Growth Rate in Bifurcation Lesions Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の根分岐部病変治療市場規模・現状・予測（2021年-2027年）

Global Bifurcation Lesions Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0749 2021年4月 92Pages
QYResearch社発行の本調査資料では、根分岐部病変治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン）、用途別市場規模（冠状血管、末梢血管）、主要地域別市場規...

世界のアレキサンドライトレーザー治療市場規模・現状・予測（2021年-2027年）

Global Alexandrite Laser Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0236 2021年4月 95Pages
QYResearch社発行の本調査資料では、アレキサンドライトレーザー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（755nmアレキサンドライトレーザー、アレキサンドライトレーザー治療器具、その他）、用途別市場規模（脱毛、刺青除去、血管病...

世界のクロファラビン市場規模・現状・予測（2021年-2027年）

Global Clofarabine Market Size, Status and Forecast 2021-2027
QYR2104Z1384 2021年4月 99Pages
QYResearch社発行の本調査資料では、クロファラビンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エボルトラ、クロファラビン）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

Global Exostosin 1/2 Heterodimer Market Size, Status and Forecast 2021-2027
QYR2104Z2272 2021年4月 92Pages
QYResearch社発行の本調査資料では、エキソストシン1/2ヘテロダイマーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

Global Micafungin Sodium for Injection Market Size, Status and Forecast 2021-2027
QYR2104Z3743 2021年4月 97Pages
QYResearch社発行の本調査資料では、注射用ミカファンギンナトリウムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（50mg使い捨てバイアル、100mg使い捨てバイアル）、用途別市場規模（カンジダ血症、呼吸器真菌症、胃腸真菌症）、主要地域...

世界の自動車におけるIIoT市場規模・現状・予測（2021年-2027年）

Global IIoT in Automotive Market Size, Status and Forecast 2021-2027
QYR2104Z3027 2021年4月 95Pages
QYResearch社発行の本調査資料では、自動車におけるIIoTのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア、ソフトウェア、サービス）、用途別市場規模（車内、自動車-自動車、自動車-インフラ）、主要地域別市場規模（北米、アメリ...

世界の先端巨大症治療市場規模・現状・予測（2021年-2027年）

Global Acromegaly Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0034 2021年4月 92Pages
QYResearch社発行の本調査資料では、先端巨大症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オクトレオチド、パシレオチド、ランレオチド、ペグビソマント）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

世界の根分岐部病変治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bifurcation Lesions Treatment Market The global Bifurcation Lesions Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界のベアメタル冠動脈ステント市場 2021：企業別、地域別、種類・用途別 The Bare Metal Coronary Artery Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
世界の血管バイパス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vascular Bypass Market The global Vascular Bypass market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
世界の血管バイパス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vascular Bypass Market The global Vascular Bypass market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
世界の末梢血管診断システム市場規模・現状・予測（2021年-2027年） The cardiovascular system is a closed vascular system consisting of the heart and blood vessels. The increasing availability of specialized cardiology and vascular specialists across the globe will drive the growth prospects for the global peripheral vascular diagnostic systems market until the end …